Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Anus Neoplasms 1

Interventions

Radiotherapy 4pembrolizumab 2aldesleukin 2Specimen Handling 2Radiation 2Mitomycin 2Drug Therapy 2Capecitabine 2Adoptive Transfer 2trastuzumab deruxtecan 1spartalizumab 1fludarabine 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Positron-Emission Tomography 1Parturition 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Induction Chemotherapy 1Immune Checkpoint Inhibitors 1Human Papillomavirus DNA Tests 1Fluorouracil 1Fluorodeoxyglucose F18 1FAPI-46 1Diagnostic Tests, Routine 1Dehydroepiandrosterone 1Cytological Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anus Neoplasms × Dehydroepiandrosterone × Clear all
NCT07407647 2026-04-21

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
25 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡